Literature DB >> 7748964

Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations.

C Schoch1, H Rieder, M Freund, D Hoelzer, H Riehm, C Fonatsch.   

Abstract

The translocation t(4;11)(q21;q23) is one of the most common specific chromosomal aberrations in acute lymphoblastic leukemia (ALL), occurring in 2% of childhood and in 5-6% of adult cases. Especially in adults, the t(4;11) is associated with a poor prognosis. In order to determine the significance of clonal chromosome aberrations that occur in addition to t(4;11), we studied the karyotypes and clinical courses of 23 patients with acute lymphoblastic leukemia and a translocation t(4;11)(q21;q23). Additional clonal chromosome aberrations were found in ten patients. An isochromosome i(7)(q10) and a trisomy 6 were observed most frequently as secondary anomalies. Clonal evolution was detected in four of six patients analyzed at diagnosis as well as at relapse. With treatment carried out according to modern risk-adapted therapy protocols, no difference in outcome was observed between patients with clonal chromosome aberrations in addition to t(4;11) at diagnosis and those without.

Entities:  

Mesh:

Year:  1995        PMID: 7748964     DOI: 10.1007/BF01700375

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease.

Authors:  H C Schouten; W G Sanger; J O Armitage
Journal:  Leuk Lymphoma       Date:  1991

2.  Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Report of the workshop held in Leuven, Belgium, April 22-23, 1985. First MIC Cooperative Study Group.

Authors: 
Journal:  Cancer Genet Cytogenet       Date:  1986-11

3.  Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): an update.

Authors:  C H Pui; L A Carroll; S C Raimondi; J J Shuster; W M Crist; D J Pullen
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

4.  Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia.

Authors:  J M Hilden; C S Chen; R Moore; J Frestedt; J H Kersey
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

5.  Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation.

Authors:  A Biondi; A Rambaldi; V Rossi; L Elia; C Caslini; G Basso; R Battista; T Barbui; F Mandelli; G Masera
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

6.  The (4;11) translocation in acute leukaemia of childhood: the importance of additional chromosomal aberrations.

Authors:  L M Secker-Walker; E L Stewart; L Chan; U O'Callaghan; J M Chessells
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

7.  Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

Authors:  A Reiter; M Schrappe; W D Ludwig; W Hiddemann; S Sauter; G Henze; M Zimmermann; F Lampert; W Havers; D Niethammer
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

8.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

Authors:  D C Tkachuk; S Kohler; M L Cleary
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11).

Authors:  F Griesinger; H Elfers; W D Ludwig; M Falk; H Rieder; J Harbott; F Lampert; B Heinze; D Hoelzer; E Thiel
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

10.  Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.

Authors:  C H Pui; L S Frankel; A J Carroll; S C Raimondi; J J Shuster; D R Head; W M Crist; V J Land; D J Pullen; C P Steuber
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

View more
  3 in total

1.  Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale.

Authors:  Heidrun D Gerr; Michele L Nassin; Elizabeth M Davis; Nimanthi Jayathilaka; Mary E Neilly; Brigitte Schlegelberger; Yanming Zhang; Janet D Rowley
Journal:  Cancer Genet Cytogenet       Date:  2007-07-15

Review 2.  MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.

Authors:  Ylenia Cicirò; Arturo Sala
Journal:  Oncogenesis       Date:  2021-02-26       Impact factor: 7.485

Review 3.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Authors:  Monica Cantile; Laura Marra; Renato Franco; Paolo Ascierto; Giuseppina Liguori; Annarosaria De Chiara; Gerardo Botti
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.